Case Control Study
Copyright ©The Author(s) 2025.
World J Gastrointest Oncol. Mar 15, 2025; 17(3): 102873
Published online Mar 15, 2025. doi: 10.4251/wjgo.v17.i3.102873
Table 3 Comparison of adverse reaction incidence, n (%)
Adverse reaction
Control (n = 21)
Observation (n = 22)
χ2
P value
Nausea and vomiting8 (38.10)6 (27.27)0.5730.449
Gastrointestinal reaction5 (23.81)4 (18.18)0.0060.937
Skin reaction3 (14.29)4 (18.18)0.0040.946
Bone marrow suppression4 (19.05)5 (22.73)0.0060.937
Liver and kidney function damage13 (61.90)11 (50.00)0.6170.432
Neurotoxicity2 (9.52)4 (18.18)0.1430.704
Leukopenia8 (38.10)7 (31.82)0.1860.665
Neutropenia5 (23.81)6 (27.27)0.0670.794
Thrombocytopenia6 (28.57)7 (31.82)0.0530.816